Transgene to Participate in Upcoming Investor Meetings

Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, todayannounced that its management team will meet institutional investors during the upcoming editions of : Investor Access Event(byInvestor Access ), onApril 1, 2025, in Paris Life Sciences Conference(byVan Lanschot Kempen ), onApril 2, 2025, in Amsterdam Next scheduled ...

Illkirch Graffenstaden, 11/03/2025 (informazione.news - comunicati stampa - economia)

(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today :

Next scheduled  :

***

Attachment